๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid

โœ Scribed by Chen, Alex M. ;Ellison, Martha E. ;Peresypkin, Andrey ;Wenslow, Robert M. ;Variankaval, Narayan ;Savarin, Cecile G. ;Natishan, Theresa K. ;Mathre, David J. ;Dormer, Peter G. ;Euler, Danielle H. ;Ball, Richard G. ;Ye, Zhixiong ;Wang, Yaling ;Santos, Ivan

Book ID
120002123
Publisher
Royal Society of Chemistry
Year
2007
Tongue
English
Weight
298 KB
Volume
4
Category
Article
ISSN
1359-7345

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Solid-state characterization of novel ac
Solid-state characterization of novel active pharmaceutical ingredients: Cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt
โœ Krzysztof J. Paluch; Lidia Tajber; Curtis J. Elcoate; Owen I. Corrigan; Simon E. ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 620 KB

The production of salt or cocrystalline forms is a common approach to alter the physicochemical properties of pharmaceutical compounds. The goal of this work was to evaluate the impact of anion choice (succinate, adipate, and sulfate) on the physicochemical characteristics of salbutamol forms. Novel

Coformer selection in pharmaceutical coc
Coformer selection in pharmaceutical cocrystal development: A case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics
โœ Miranda L. Cheney; David R. Weyna; Ning Shan; Mazen Hanna; Lukasz Wojtas; Michae ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 475 KB

Meloxicam is a nonsteroidal anti-inflammatory drug with low aqueous solubility and high permeability. Because of its low solubility under acidic conditions (e.g., pH 1-5), it can take more than 2 h for meloxicam to reach its therapeutic concentration in humans. Although the slow onset of meloxicam d